Table 1 Baseline characteristics of the studied patients in both groups
|  | Control group (n = 35) | Omega 3 group (n = 35) | P |
|---|---|---|---|
Age (year) | 52.42 ± 7.64 | 50.51 ± 8.42 | 0.323 |
Gender (Male/Female) | 21 (60)/14(40) | 17 (48.6)/ 18 (51.4) | 0.337 |
Smoker | 8 (22.9) | 12 (34.3) | 0.290 |
HTN | 12 (34.3) | 13 (37.1) | 0.803 |
Dyslipidemia | 6 (17.1) | 2 (5.7) | 0.133 |
ACEIs | 9 (25.7) | 8 (22.9) | 0.780 |
ARBs | 3 (8.6) | 0 (0) | 0.080 |
Beta Blocker | 4 (11.4) | 8 (22.9) | 0.205 |
CCB | 6 (17.1) | 4 (11.4) | 0.495 |
Statin | 10 (28.6) | 5 (14.3) | 0.145 |